Evidano home
Commentary on News

AI Qualitative Analysis for Healthcare: HCV Access

Evidano8 min read

Healthcare researchers need to connect prevalence data with the lived experiences behind delayed or missed treatment. The November 20, 2026 study in PLOS One on Hepatitis C virus treatment access in Los Angeles County shows why AI qualitative analysis in healthcare can support, but not replace, careful human interpretation. The study combined de-identified program data from 344 case-residents with semi-structured interviews involving 10 participants, including seven untreated and three treated participants. Researchers found that quantitative categories identified the scale of reported barriers, while interview analysis explained how language, cost, transportation, provider delays, homelessness, incarceration, and stigma shaped treatment journeys. Evidano is an AI-powered qualitative data analysis platform that helps healthcare researchers analyze interviews, open-ended surveys, and documents. This article summarizes the study’s findings and shows how thematic, frequency, and cross-segment analysis can help research teams move from transcripts to actionable questions about access, trust, and care coordination.

Key Takeaways

The November 20, 2026 PLOS One mixed-methods study found that Hepatitis C treatment access in Los Angeles County was constrained by personal, provider-related, insurance, and healthcare access barriers.

AI qualitative analysis in healthcare can help researchers organize recurring themes, compare treated and untreated participants, and connect qualitative explanations with quantitative program data, while human researchers remain responsible for interpretation and ethical decisions.

  • Between October 2024 and January 2025, researchers analyzed de-identified program data from 344 Los Angeles County case-residents and conducted interviews with 10 participants.
  • The study reported that 54% of case-residents experienced barriers, while personal barriers accounted for 43% of specific barriers, provider-related barriers for 31%, insurance barriers for 13%, and inadequate medical access for 13%.
  • The qualitative sample included seven untreated participants and three treated participants, enabling comparison of barriers before treatment with facilitators that supported treatment completion.
  • Interview themes included homelessness, incarceration, drug addiction, language barriers, long wait times, transportation problems, limited HCV information, family support, provider trust, and treatment motivation.
  • The authors recommended language support, patient navigation, care coordination, mobile clinics for people experiencing homelessness, treatment continuity after incarceration, and fewer insurance restrictions.

What the HCV Treatment Access Study Measured

The study used a convergent parallel mixed-methods design to measure both the frequency of reported barriers and the experiences behind those barriers. According to the November 20, 2026 PLOS One study, quantitative and qualitative data were collected during the same October 2024 to January 2025 period, analyzed separately, and merged during interpretation.

The quantitative component used frequencies and percentages from Project HCV Connect, a Los Angeles County linkage-to-cure program. The qualitative component used 30- to 60-minute semi-structured interviews conducted in English and Spanish, followed by verbatim transcription and inductive thematic analysis.

The researchers wrote that linkage-to-cure data could show “how often treated and untreated HCV individuals reported barriers and which types they reported, but not why those barriers occurred.” The study used interviews to supply that missing context.

The authors also reported that all transcripts were independently coded by members of the research team, who met to compare codes and resolve discrepancies. The study did not conduct member-checking or participant transcript validation, and the authors described the qualitative findings as exploratory.

HCV Treatment Access Findings Snapshot

Date or periodMeasureValueResearch implication
October 2024 to January 2025Case-residents contacted344The program data provided the quantitative foundation for the mixed-methods analysis.
October 2024 to January 2025Case-residents already treated168, or 49%Treatment status enabled comparison between treated and untreated groups.
October 2024 to January 2025Case-residents not treated176The untreated group highlighted obstacles to treatment initiation.
October 2024 to January 2025Case-residents reporting barriers54%More than half of the program participants reported at least one treatment access barrier.
October 2024 to January 2025Interviews completed10 participantsThe interviews added context that program frequencies could not provide.
October 2024 to January 2025Interview sample7 untreated and 3 treated participantsThe sample supported exploratory comparison across treatment status.
2019 to 2023People diagnosed with HCV in Los Angeles County27, 678The study placed local treatment access barriers within a substantial diagnosed population.
2019 to 2023People completing HCV treatment32%Low completion rates reinforced the need to understand barriers beyond diagnosis.

What AI Qualitative Analysis Adds for Healthcare Researchers

How can researchers identify barriers across interviews?

AI qualitative analysis can help researchers surface recurring themes such as cost, language, transportation, provider follow-up, stigma, and limited treatment knowledge across a transcript collection.

The November 20, 2026 PLOS One study shows why frequency alone is insufficient: a reported category such as a provider barrier does not explain the frustration, confusion, or repeated failed attempts that may sit behind a participant’s answer.

How can researchers compare treated and untreated participants?

Cross-segment analysis can compare untreated and treated participants by treatment status, language, insurance, or other study variables, provided the research team has appropriate data and safeguards.

In the PLOS One study, untreated participants described cost, language, transportation, information, and system-navigation barriers, while treated participants described homelessness, incarceration, drug addiction, and long waits, alongside facilitators such as family support and provider trust.

How can qualitative findings guide intervention design?

Thematic analysis can translate participant language into intervention targets, such as bilingual education, navigation support, improved referral coordination, transportation assistance, or mobile care.

The study authors recommended equitable interventions that address both individual and system-level barriers, rather than treating delayed treatment as an individual motivation problem alone.

How Evidano Supports AI Qualitative Analysis in Healthcare

Problem: Large transcript collections slow thematic synthesis

Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents.

Evidano can support thematic, content, and frequency analysis across interview transcripts and reports, helping teams organize recurring HCV access themes before researchers review the evidence and refine the interpretation.

Researchers can review Evidano’s qualitative research features when planning a mixed-methods workflow.

Problem: Language differences can hide comparable experiences

Evidano supports transcription and translation workflows that can help research teams process multilingual interviews while preserving a custom dictionary for study-specific terminology.

For studies involving English- and Spanish-speaking participants, researchers should verify translated outputs against source audio or transcripts and document how language was handled analytically. The PLOS One study specifically identified language barriers as an important treatment access theme.

Problem: Researchers need to compare segments without losing context

Evidano supports cross-segment analysis and visualizations such as hierarchical codes, subcodes, word clouds, and co-occurrence networks.

A healthcare research team could use these views to compare treated and untreated participants, identify themes that co-occur with provider frustration or cost, and return to the underlying excerpts for human review.

Problem: Sensitive health data requires careful handling

Healthcare researchers should use de-identification, access controls, and documented review procedures when analyzing participant narratives.

Evidano provides encrypted data handling and states that customer data is never used to train third-party models; teams should still follow their institutional review board requirements, consent terms, and applicable privacy policies.

FAQ: AI Qualitative Analysis in Healthcare

What is AI qualitative analysis in healthcare?

AI qualitative analysis in healthcare uses artificial intelligence to help organize, code, summarize, compare, and query interviews, open-ended responses, and documents.

AI can accelerate pattern discovery, but healthcare researchers must validate themes against source material and retain responsibility for methodological and ethical judgments.

What were the main Hepatitis C treatment barriers in the Los Angeles County study?

The main barriers were personal circumstances, provider-related problems, insurance barriers, inadequate medical access, language barriers, cost, transportation, limited information, and difficulty navigating the healthcare system.

According to the November 20, 2026 PLOS One study, 54% of 344 case-residents reported barriers, with personal barriers representing 43% of specific reported barriers.

How many participants were interviewed in the HCV access study?

The study interviewed 10 participants, including seven untreated participants and three treated participants.

The small qualitative sample means the findings provide exploratory insight rather than statistically generalizable estimates for all Los Angeles County residents.

Can AI replace researchers in thematic analysis?

AI cannot replace researchers in thematic analysis because researchers must define the study purpose, assess context, evaluate ambiguity, protect participants, and justify conclusions.

The PLOS One research team independently coded transcripts, compared codes, and resolved discrepancies, illustrating the importance of collaborative human review in qualitative rigor.

What interventions did the HCV study recommend?

The study recommended language support, patient navigation, care coordination, mobile clinics for people experiencing homelessness, continuity of treatment after incarceration, and removal of insurance restrictions such as prior authorization requirements.

These recommendations should be adapted to local populations and evaluated through further research rather than assumed to work equally in every setting.

Conclusion and Next Steps for Healthcare Research Teams

The November 20, 2026 PLOS One study demonstrates how mixed-methods research can connect barrier frequencies with the lived experiences of people navigating HCV treatment. AI qualitative analysis can help healthcare teams process multilingual interviews, compare patient segments, identify co-occurring themes, and create an auditable path from raw transcript to research question. Human researchers must still validate codes, protect sensitive data, and avoid treating exploratory findings as universal evidence. To organize healthcare interviews and open-ended responses more efficiently, try Evidano for free.

Topics

  • AI qualitative analysis healthcare
  • AI thematic analysis healthcare
  • Hepatitis C treatment barriers
  • qualitative healthcare research
  • mixed-methods healthcare research

Keep reading

Browse all articles